Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Children’s National Medical Center – $300,000

Amount
$300,000.00
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Grant Information

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.

Grant Information

The Institute of Cancer Research – $111,445 USD / £85,976 GBP

Amount
$111,445.00
Date
October 2024

Unravelling transcriptional plasticity as a non-genetic mechanism of drug resistance in DMG.

Grant Information

Children’s Cancer Institute – $100,000 USD / $150,589 AUD

Amount
$100,000.00
Date
October 2024

Targeting lactate production pathways as a novel therapy against DIPG

Grant Information

McGill University - $100,000

Amount
$100,000.00
Date
October 2024

Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.

Grant Information

Cincinnati Children’s Hospital Medical Center - $200,000

Amount
$200,000.00
Date
October 2024

Combining FLASH and immunotherapy to target medulloblastoma relapse

Grant Information

Emory University / Cincinnati Children's Hospital – $93,250

Amount
$93,250.00
Date
March 2024

SUMOylation as a novel therapeutic target in DIPG

Grant Information

University of Chicago Medical Center / Washington University St. Louis – $100,000

Amount
$100,000.00
Date
December 2023

Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.

Grant Information

Icahn School of Medicine at Mount Sinai – $100,000

Amount
$100,000.00
Date
December 2023

Targeting macrophages to improve the survival of DIPG

Grant Information

Children’s Cancer Institute – $50,000

Amount
$50,000.00
Date
December 2023

A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.

Grant Information

Children’s Hospital Colorado – $100,000

Amount
$100,000.00
Date
December 2023

Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.

Grant Information

University of Newcastle – $116,997 USD, 173,016 AUD

Amount
$116,997.00
Date
December 2023

(2023) Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies.

Grant Information

Princess Máxima Center for Pediatric Oncology – $98,306

Amount
$98,306.00
Date
December 2023

Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.

Grant Information

Nemours Children’s Hospital - $50,000

Amount
$50,000.00
Date
December 2023

Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.

Grant Information

Icahn School of Medicine at Mount Sinai - $100,000

Amount
$100,000.00
Date
December 2023

Preclinical evaluation of TP-0184 in an autochthonous mouse model of DIPG/DMG

Grant Information